Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial.
Quillien V, Lavenu A, Ducray F, Joly MO, Chinot O, Fina F, Sanson M, Carpentier C, Karayan-Tapon L, Rivet P, Entz-Werle N, Legrain M, Zalcman EL, Levallet G, Escande F, Ramirez C, Chiforeanu D, Vauleon E, Figarella-Branger D. Quillien V, et al. Among authors: ducray f. Oncotarget. 2016 Sep 20;7(38):61916-61929. doi: 10.18632/oncotarget.11322. Oncotarget. 2016. PMID: 27542245 Free PMC article.
No association of MDM2 SNP309 with risk of glioblastoma and prognosis.
El Hallani S, Marie Y, Idbaih A, Rodero M, Boisselier B, Laigle-Donadey F, Ducray F, Delattre JY, Sanson M. El Hallani S, et al. Among authors: ducray f. J Neurooncol. 2007 Dec;85(3):241-4. doi: 10.1007/s11060-007-9416-1. Epub 2007 Jun 14. J Neurooncol. 2007. PMID: 17568997
TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A, Boisselier B, Marie Y, El Hallani S, Sanson M, Crinière E, Rodero M, Carpentier C, Paris S, Laigle-Donadey F, Ducray F, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: ducray f. Cancer Genet Cytogenet. 2007 Sep;177(2):103-7. doi: 10.1016/j.cancergencyto.2007.06.010. Cancer Genet Cytogenet. 2007. PMID: 17854663
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Kaloshi G, Everhard S, Laigle-Donadey F, Marie Y, Navarro S, Mokhtari K, Idbaih A, Ducray F, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M. Kaloshi G, et al. Among authors: ducray f. Neurology. 2008 Feb 19;70(8):590-5. doi: 10.1212/01.wnl.0000299896.65604.ae. Neurology. 2008. PMID: 18285534 Clinical Trial.
Genomic changes in progression of low-grade gliomas.
Idbaih A, Carvalho Silva R, Crinière E, Marie Y, Carpentier C, Boisselier B, Taillibert S, Rousseau A, Mokhtari K, Ducray F, Thillet J, Sanson M, Hoang-Xuan K, Delattre JY. Idbaih A, et al. Among authors: ducray f. J Neurooncol. 2008 Nov;90(2):133-40. doi: 10.1007/s11060-008-9644-z. Epub 2008 Jul 11. J Neurooncol. 2008. PMID: 18618226
TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
El Hallani S, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, Laigle-Donadey F, Rodéro M, Chinot O, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M. El Hallani S, et al. Among authors: ducray f. Neurology. 2009 Jan 27;72(4):332-6. doi: 10.1212/01.wnl.0000341277.74885.ec. Neurology. 2009. PMID: 19171829
IDH1 and IDH2 mutations in gliomas.
Ducray F, Marie Y, Sanson M. Ducray F, et al. N Engl J Med. 2009 May 21;360(21):2248-9; author reply 2249. N Engl J Med. 2009. PMID: 19469031 No abstract available.
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.
Labussière M, Idbaih A, Wang XW, Marie Y, Boisselier B, Falet C, Paris S, Laffaire J, Carpentier C, Crinière E, Ducray F, El Hallani S, Mokhtari K, Hoang-Xuan K, Delattre JY, Sanson M. Labussière M, et al. Among authors: ducray f. Neurology. 2010 Jun 8;74(23):1886-90. doi: 10.1212/WNL.0b013e3181e1cf3a. Epub 2010 Apr 28. Neurology. 2010. PMID: 20427748
217 results